Matching slides 24,547
Current window 16,051-16,080
Pages 819
Rows per page 30
Slide function: Present Solutionclear collectionreset all

Slide function

16,051-16,080 of 24,547

filter-aware
28
Exscientia | Investor Presentation Deck | 75 slidesExscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
32
The slide shows a heatmap of 43 patient samples across different cancer types, correlating ABS with signature scores.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
41
The slide uses a three-column layout to define the target product profile (TPP) requirements for a drug candidate.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
45
The slide uses a heatmap to display binary synergy results (Yes/No) across three drug combinations, alongside a bar chart showing single-agent sensitivity.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
46
The slide uses a Venn diagram to illustrate the overlap of gene modulation between peripheral blood and primary tumours, and line charts to show dose-response curves for two specific biomarkers.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
47
The slide features a 3D molecular visualization of the protein target.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
48
TPP stands for Target Product Profile.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
50
The slide uses a process-flow layout to describe the company's R&D methodology.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
52
Exscientia | Investor Presentation Deck | 75 slidesExscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
53
Includes two scientific diagrams illustrating the mechanism of action and brain penetration.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
54
The slide uses a three-column layout to define technical requirements for a drug candidate.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
56
The slide uses a linear process framework to explain the drug discovery pipeline.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
57
The slide uses a Pareto front to illustrate the trade-off between CNS score and Potency, highlighting the selection of 'unattractive' compounds.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
59
The slide uses two distinct chart types (dot plot and line chart) to demonstrate the safety profile of a reversible inhibitor.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
61
The slide uses a two-column layout to contrast PK data with Toxicology/Safety data.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
64
Exscientia | Investor Presentation Deck | 75 slidesExscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
66
Exscientia | Investor Presentation Deck | 75 slidesExscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
67
The slide uses a scientific mechanism-of-action argument to establish a competitive moat.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
69
The slide uses a process-based framework to show how MD and AI are integrated into a drug discovery workflow.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
70
The image shows a protein binding site with color-coded regions (Donor, Apolar, Acceptor) indicating chemical properties.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
72
The chart shows tumor volume over time (D20-D30), with the combination therapy (teal line) showing a flat growth curve compared to monotherapies and vehicle controls.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
73
Exscientia | Investor Presentation Deck | 75 slidesExscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
06
The slide uses a cyclical process flow to represent an adaptive clinical trial framework.Exscientia | Results Presentation Deck | 19 slides · Exscientia
Conference presentation Investor relations Beat · Need1 hit
07
The slide uses a visual list of protein structures to represent drug candidates.Exscientia | Results Presentation Deck | 19 slides · Exscientia
Conference presentation Investor relations Beat · Need1 hit
10
The chart uses a horizontal bar format to represent development stages. One bar is orange (EXS4318), while the others are teal.Exscientia | Results Presentation Deck | 19 slides · Exscientia
Conference presentation Investor relations Beat · SatisfactionLoop · Pattern Hunter1 hit
16
The Venn diagram illustrates the overlap of genes modulated by '617 in peripheral blood vs primary tumours, highlighting the potential for non-invasive biomarker monitoring.Exscientia | Results Presentation Deck | 19 slides · Exscientia
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
10
The slide uses a visual metaphor of a single car morphing into three different vehicle archetypes to demonstrate the technology's adaptability.Faraday Future | Results Presentation Deck | 36 slides · Faraday Future
Conference presentation Investor relations Beat · Satisfaction1 hit
12
Faraday Future | Results Presentation Deck | 36 slidesFaraday Future | Results Presentation Deck | 36 slides · Faraday Future
Conference presentation Investor relations Beat · Satisfaction1 hit
13
The slide uses a cross-section diagram of a vehicle chassis to demonstrate structural safety.Faraday Future | Results Presentation Deck | 36 slides · Faraday Future
Conference presentation Investor relations Beat · Satisfaction1 hit
14
The slide uses a grid of four images to highlight core technological advantages of the Faraday Future vehicle.Faraday Future | Results Presentation Deck | 36 slides · Faraday Future
Conference presentation Investor relations Beat · Satisfaction1 hit